Literature DB >> 7490157

Biological determinants of aldosterone-induced cardiac fibrosis in rats.

V Robert1, J S Silvestre, D Charlemagne, A Sabri, P Trouvé, M Wassef, B Swynghedauw, C Delcayre.   

Abstract

To determine the events leading to cardiac fibrosis in aldosterone-salt hypertensive rats, we studied protein and mRNA accumulation of procollagens I and III for 60 days. After 3 and 7 days of treatment systolic pressure was normal, and no histological or biochemical changes were seen in rat hearts. At day 15 arterial pressure was raised (+40%) and left ventricular hypertrophy was +15%. Cardiac examination after hemalun-eosin staining and immunolabeling with anticollagen I and III antibodies showed no structural alterations, but an 83% increase in right ventricular type III procollagen mRNA levels was found. At 30 and 60 days we found progressive cardiac fibrosis, with inflammatory cells, myocyte necrosis, and elevation of both types I and III procollagen mRNA levels in both ventricles. To determine whether aldosterone had effects on Na,K-ATPase that might lead to ionic disturbances and induce myocyte necrosis, we studied the major cardiac Na,K-ATPase isoform genes. Although Na,K-ATPase alpha 1- and beta 1-subunit mRNA levels were elevated in kidney at day 1, neither of these cardiac transcripts nor the specific alpha 2 isoform was altered between 1 and 15 days. These results show that accumulation of procollagen mRNAs occurs before collagen deposition. Cardiac alterations are late and not preceded by changes in Na,K-ATPase cardiac gene expression, precluding a direct modulation of cardiac collagen synthesis and Na,K-ATPase by aldosterone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490157     DOI: 10.1161/01.hyp.26.6.971

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure.

Authors:  Kurt R Daniel; Gretchen Wells; Kathryn Stewart; Brian Moore; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2009 Mar-Apr

Review 2.  Circulating biomarkers in patients with heart failure and preserved ejection fraction.

Authors:  Eileen O'Meara; Simon de Denus; Jean-Lucien Rouleau; Akshay Desai
Journal:  Curr Heart Fail Rep       Date:  2013-12

3.  Serum concentration of procollagen type III amino-terminal peptide is increased in patients with successfully repaired coarctation of the aorta with left ventricular hypertrophy.

Authors:  Hirokuni Yamazawa; Tomoaki Murakami; Atsuhito Takeda; Kouta Takei; Takuo Furukawa; Hiromichi Nakajima
Journal:  Pediatr Cardiol       Date:  2014-10-14       Impact factor: 1.655

4.  Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias.

Authors:  Antoine Ouvrard-Pascaud; Yannis Sainte-Marie; Jean-Pierre Bénitah; Romain Perrier; Christelle Soukaseum; Aurelie Nguyen Dinh Cat; Anne Royer; Khai Le Quang; Flavien Charpentier; Sophie Demolombe; Fatima Mechta-Grigoriou; Ahmed T Beggah; Pierre Maison-Blanche; Marie-Edith Oblin; Claude Delcayre; Glenn I Fishman; Nicolette Farman; Brigitte Escoubet; Frederic Jaisser
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

5.  Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Authors:  Ahmed T Beggah; Brigitte Escoubet; Stefania Puttini; Stephane Cailmail; Vanessa Delage; Antoine Ouvrard-Pascaud; Brigitte Bocchi; Michel Peuchmaur; Claude Delcayre; Nicolette Farman; Frederic Jaisser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 6.  Rationale for the use of aldosterone antagonists in congestive heart failure.

Authors:  Ricardo Rocha; Gordon H Williams
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.

Authors:  Young-Sam Lee; Jeong-A Kim; Koung Li Kim; Hyung-Suk Jang; Jeong-Min Kim; Jae-Young Lee; In-Soon Shin; Jung-Sun Lee; Wonhee Suh; Jin-Ho Choi; Eun-Seok Jeon; Jonghoe Byun; Duk-Kyung Kim
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

8.  Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Authors:  Li-Jun Ma; Haichun Yang; Ariana Gaspert; Gianluca Carlesso; Melissa M Barty; Jeffrey M Davidson; Dean Sheppard; Agnes B Fogo
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 9.  Aldosterone receptor antagonists for hypertension: what do they offer?

Authors:  Danny Liew; Henry Krum
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

Authors:  Siva S V P Sakamuri; Anthony J Valente; Jalahalli M Siddesha; Patrice Delafontaine; Ulrich Siebenlist; Jason D Gardner; Chandrasekar Bysani
Journal:  Mol Cell Endocrinol       Date:  2016-04-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.